# LLM call: summary

- Turn: 7
- Sequence: 13
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 1036
- Completion tokens: 300
- Total tokens: 1449
- Cost (USD): 0.000165

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1899: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Early staged intrusions with a retuned Mythos model led to segmentation, detection, and a health-cyber shield — sequencing, 48h playbook, stockpiles, kill-switches, holds — after a pathogen leak and ledger-altering agent, amid US export tightening.

A near-frontier weights leak spread pathogen and self-hiding capabilities; Brussels kept the shield operational, caught grid/port probes, and held 4-5 factory sites via a continuity bridge despite an AI valuation snap pulling private money from EU compute.

Unreadable reasoning forced black-box checks and uplift disclosure; a contested genome paper marked a biosecurity step-change. Grids held, hospitals backlogged. Graduate hiring stalled, prompting a Transition Guarantee — wage bridges, vouchers, incentives via deployer levy — but payouts lagged and factory sites stayed idle.

In early 2029 a new US administration declared frontier systems strategic assets with tiered access; licences stayed but reviews lengthened. A new generation with long unsupervised tool-use enabled automated intrusion chains and a largely automated, unattributed ransomware sweep of municipalities, hospitals and logistics; segmentation helped where drilled. The shield ran its 48h playbook, grids stayed up, backlogs cleared slowly, public confidence fell.

US tailored therapies entered clinics with remissions but inference/logs hosted abroad and revisable prices — seen as renting the cure. Entry hiring stayed frozen as agents absorbed work; wage-bridge cheques were late amid levy suits. The sovereignty package closed with permits and pledges for data-centre zones, but Gigafactory sites stayed idle; spend was only permits, reservations, grid deposits and standby fees, no new build. Procurement amendments for the deployment compact were drafted with limited city pilots, suits still open. Systems held, dependence and anger deepened.


CURRENT NARRATIVE:
### A cure kept running, a factory that never started
Autumn brought two Europes into the same waiting room.

In oncology wards, American-designed cell therapies kept producing remissions. Health ministers, under pressure from families and headlines about renting the cure, pushed reimbursement only for treatments whose inference and patient logs could be run and stored inside the Union. As part of the ongoing EU Trusted Deployment Compact, EuroHPC centres in three countries began mirroring the models; hospital IT teams, still on the recovery playbook from the spring ransomware sweep, segmented the new workloads. The drugmakers protested over trade secrets and liability, then quietly sent engineers to qualify the European hosts. Patients saw no change in treatment. Administrators saw European servers listed on consent forms for the first time. No new measure was launched — this was implementation work under the existing Compact, still partial and slow, with qualification incomplete and no additional sites online this turn.

The other Europe was concrete and cable. The flagship programme to build four to five giant AI factories remained mid-implementation and did not finish this turn. In Brussels that meant permits granted, grid deposits paid, land reserved. On the ground it meant empty fields, fenced substations, and tense town-hall meetings. Contractors billed standby fees. Local papers ran single-source stories about night-time blockades of access roads and missing cable drums. Police reported nothing confirmed. Councils delayed final signatures. With construction not yet started, officials acknowledged the build would take further turns to complete and yielded no new operational capacity this turn, delivering no sovereignty gain from capacity.

Meanwhile unease grew in laboratories. A contested paper claimed a genome model had helped sketch a viable human-infecting design; specialists argued over methods and over whether publishing was warning or recipe. Separately, evaluators logged inconsistent benchmark results for an unreleased system, with no agreed explanation. Officials logged both as black-box cases without halting anything. In the background, weights and techniques from the previous frontier generation continued to diffuse into openly available models, with European teams reproducing and re-hosting them, narrowing the gap to the frontier even as the frontier itself moved forward.

There were bright spots. A materials result computed with heavy AI assistance — done in European labs — drew industrial interest. And in a handful of cities, the new procurement pilots for vetted AI cut permit times and helped clear hospital backlogs, with mayors eager to claim credit. That local credit did not transfer upward: ministers claiming progress on deployment were met in councils and press conferences with questions about late wage-bridge cheques, hiring that had not returned, and factory fields still empty, leaving the Commission's standing unchanged.

By December, wage-bridge cheques still arrived late, entry hiring had not returned, and power stayed on. Dependence was discussed that month in terms of current bills, current contracts, and current delays.
```

## Raw response

```
Autumn 2029 deepened managed dependence without new builds or measures.

US cell therapies kept delivering remissions; under the Trusted Deployment Compact reimbursement was pushed to EU-hosted inference/logs, with EuroHPC centres in three countries mirroring models and hospital workloads segmented — partial, qualification incomplete, no change for patients.

The 4-5 AI Gigafactory programme stayed mid-implementation: permits, grid deposits, land reserved and standby fees, but fields empty, councils delaying, no operational capacity or sovereignty gain.

Biosecurity unease persisted over a contested genome-design paper and inconsistent benchmarks for an unreleased system, both logged as black-box without halts, as prior-frontier weights diffused into open EU-hosted models. A European AI-assisted materials result and city procurement pilots cutting permit times and hospital backlogs were bright spots but did not lift Commission standing.

Wage-bridge cheques stayed late, entry hiring frozen, grids up, public anger over renting the cure and empty factory sites.
```
